We looked at the distribution of breakpoints in ALK, RET, ROS1, NTRK1, as well as other kinase genes known to generate oncogenic fusions in lung cancer, such as EGFR, ERBB4, MET, FGFR3, and EPHA245. This evidence concerns the gene RET and lung cancer.